RASL10B and neoplasm: Among them, we selected five decreased (CCDC28B, SREK1IP1/P18SRP/SFRS12IP1, RASL10B, PHF21A/BHC80 and PGC) and two increased genes (IL-11 and CXCL2), by microarray, as differentiation-, splicing-, inflammation-, or tumor-related genes.